SCHEMBL19990380

SCHEMBL19990380

CC(C)(C)OC(=O)NC[C@@H]1C/C(=N\OCC(N)=O)[C@@H]2CN1C(=O)N2OS(=O)(=O)ON1C(=O)N2C[C@H]1/C(=N/OCC(N)=O)C[C@H]2CNC(=O)OC(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19990381 0.94 — —
SCHEMBL20024778 0.88 — —
SCHEMBL19990375 0.85 — —
SCHEMBL18113993 0.85 — —
SCHEMBL19990376 0.85 — —
SCHEMBL18114010 0.83 — —
SCHEMBL18113996 0.82 ACACB (0.33) —
SCHEMBL19999935 0.77 — —
SCHEMBL21754458 0.75 ACACB (0.33) —
SCHEMBL18113998 0.75 ACACB (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3300736-B1 COMPOSITION COMPRISING ANTIBIOTIC COMPOUND AND AN HETEROCYCLIC COMPOUND AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS MUTABILIS (FR) 2021-05-05 — — EP disclosed
EP-3277685-B1 HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS MUTABILIS (FR) 2021-01-13 — — EP disclosed
US-10570131-B2 Heterocyclic compounds and their use in preventing or treating bacterial infections MUTABILIS (FR) 2020-02-25 — — US disclosed
WO-2018060484-A1 COMPOSITION COMPRISING ANTIBIOTIC COMPOUND AND AN HETEROCYCLIC COMPOUND AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS MUTABILIS (FR) 2018-04-05 — — WO disclosed
EP-3300736-A1 COMPOSITION COMPRISING ANTIBIOTIC COMPOUND AND AN HETEROCYCLIC COMPOUND AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS Mutabilis (FR) 2018-04-04 — — EP disclosed
US-20180086760-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS MUTABILIS (FR) 2018-03-29 — — US disclosed
Send feedback